Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tick-borne encephalitis in Norway].

Tone Skarpaas1, Anders Sundøy, Anne-Lise Bruu

  • 1Mikrobiologisk avdeling, Vest-Agder Sentralsykehus 4604 Kristiansand.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 20, 2002
PubMed
Summary

Tick-borne encephalitis (TBE) is confirmed in Norway, with cases linked to Tromøy island. Seroprevalence studies reveal a higher incidence of TBE antibodies on Tromøy compared to surrounding areas.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, Sweden.

The Journal of infectious diseases·2024
Same author

Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.

JMIR public health and surveillance·2024
Same author

Seroprevalence of tick-borne encephalitis virus and vaccination coverage of tick-borne encephalitis, Sweden, 2018 to 2019.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2024
Same author

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit.

JMIR public health and surveillance·2023
Same author

VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.

Vaccine·2022
Same author

Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.

Vaccine·2022

Area of Science:

  • Medical Entomology
  • Virology
  • Epidemiology

Background:

  • The first reported cases of tick-borne encephalitis (TBE) in Norway occurred in 1998 and 1999, with both patients having visited Tromøy island.
  • Intensified surveillance for TBE antibodies in encephalitis patients and a seroprevalence study were initiated following these cases.

Observation:

  • Three cases of TBE were identified, including two with encephalitis in late 2000 and one retrospectively diagnosed case from August 1997.
  • Serological testing of individuals from Tromøy between 1997 and 2000 detected TBE virus IgG antibodies in 2.4% of samples.

Findings:

  • The study identified the first cases of TBE in Norway, with a significant proportion of early cases linked to exposure on Tromøy island.
  • Seroprevalence data suggests a potentially higher incidence of TBE on Tromøy compared to other southern Norwegian counties, with 2.4% of residents showing IgG antibodies.

Related Experiment Videos

Implications:

  • These findings confirm the presence of TBE in coastal southern Norway and highlight Tromøy as a potential endemic area.
  • The results underscore the importance of TBE surveillance and public awareness in affected regions of Norway.